6.41
price down icon8.43%   -0.59
after-market After Hours: 6.41
loading
Novavax Inc stock is traded at $6.41, with a volume of 4.62M. It is down -8.43% in the last 24 hours and down -23.05% over the past month.
See More
Previous Close:
$7.00
Open:
$6.49
24h Volume:
4.62M
Relative Volume:
1.15
Market Cap:
$1.17B
Revenue:
$847.25M
Net Income/Loss:
$-284.86M
P/E Ratio:
-2.7991
EPS:
-2.29
Net Cash Flow:
$-112.35M
1W Performance:
-16.64%
1M Performance:
-23.05%
6M Performance:
-49.25%
1Y Performance:
+34.10%
1-Day Range:
Value
$6.28
$6.59
1-Week Range:
Value
$6.28
$7.715
52-Week Range:
Value
$3.81
$23.86

Novavax Inc Stock (NVAX) Company Profile

Name
Name
Novavax Inc
Name
Phone
240-268-2000
Name
Address
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
Employee
0
Name
Twitter
@novavax
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
NVAX's Discussions on Twitter

Compare NVAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NVAX
Novavax Inc
6.41 1.17B 847.25M -284.86M -112.35M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Initiated BTIG Research Buy
Jul-30-24 Downgrade JP Morgan Neutral → Underweight
May-10-24 Upgrade BofA Securities Underperform → Neutral
May-10-24 Upgrade JP Morgan Underweight → Neutral
Aug-09-23 Upgrade B. Riley Securities Neutral → Buy
Apr-20-23 Downgrade TD Cowen Outperform → Market Perform
Mar-01-23 Downgrade B. Riley Securities Buy → Neutral
Jan-09-23 Reiterated B. Riley Securities Buy
Dec-30-22 Reiterated H.C. Wainwright Buy
Dec-02-22 Initiated Jefferies Hold
Sep-22-22 Downgrade JP Morgan Neutral → Underweight
May-20-22 Initiated BofA Securities Underperform
Feb-23-22 Reiterated B. Riley Securities Buy
Feb-22-22 Resumed Jefferies Buy
Jan-21-22 Initiated Cowen Outperform
May-12-21 Downgrade JP Morgan Overweight → Neutral
Dec-14-20 Initiated Jefferies Buy
Aug-06-20 Reiterated H.C. Wainwright Buy
Aug-05-20 Upgrade JP Morgan Neutral → Overweight
Aug-05-20 Downgrade Ladenburg Thalmann Neutral → Sell
Jul-16-20 Reiterated H.C. Wainwright Buy
Jul-08-20 Downgrade Ladenburg Thalmann Buy → Neutral
Jun-29-20 Reiterated B. Riley FBR Buy
Jun-29-20 Reiterated H.C. Wainwright Buy
Jun-05-20 Upgrade JP Morgan Underweight → Neutral
May-28-20 Reiterated B. Riley FBR Buy
May-12-20 Reiterated H.C. Wainwright Buy
Apr-30-20 Reiterated H.C. Wainwright Buy
Nov-27-19 Resumed B. Riley FBR Buy
Aug-14-19 Reiterated H.C. Wainwright Buy
Feb-28-19 Downgrade Piper Jaffray Overweight → Underweight
Dec-18-18 Initiated Ladenburg Thalmann Buy
Dec-11-18 Initiated Oppenheimer Outperform
Nov-26-18 Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18 Upgrade JP Morgan Underweight → Overweight
Mar-29-18 Upgrade Seaport Global Securities Neutral → Buy
View All

Novavax Inc Stock (NVAX) Latest News

pulisher
05:28 AM

Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch

05:28 AM
pulisher
04:26 AM

Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ

04:26 AM
pulisher
04:09 AM

Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe

04:09 AM
pulisher
02:42 AM

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company

02:42 AM
pulisher
01:21 AM

Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief - MarketScreener

01:21 AM
pulisher
01:07 AM

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance

01:07 AM
pulisher
11:01 AM

Vaccine Makers Plunge After FDA Biologics Head Marks Steps Down - Bloomberg.com

11:01 AM
pulisher
10:26 AM

Biopharma, Biotech stocks tumble on FDA shakeup - Investing.com India

10:26 AM
pulisher
09:00 AM

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

09:00 AM
pulisher
Mar 30, 2025

Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance

Mar 30, 2025
pulisher
Mar 28, 2025

Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch

Mar 28, 2025
pulisher
Mar 27, 2025

Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Mar 27, 2025
pulisher
Mar 26, 2025

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Where are the Opportunities in (NVAX) - Stock Traders Daily

Mar 26, 2025
pulisher
Mar 25, 2025

Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 25, 2025
pulisher
Mar 25, 2025

The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice

Mar 25, 2025
pulisher
Mar 24, 2025

Novavax Inc. stock rises Monday, still underperforms market - MarketWatch

Mar 24, 2025
pulisher
Mar 24, 2025

Ebola Vaccine Market Generated Opportunities, Future Scope - openPR

Mar 24, 2025
pulisher
Mar 19, 2025

Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Mar 19, 2025
pulisher
Mar 17, 2025

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

Mar 17, 2025
pulisher
Mar 17, 2025

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance

Mar 17, 2025
pulisher
Mar 15, 2025

(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 15, 2025
pulisher
Mar 15, 2025

2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying - The Motley Fool

Mar 15, 2025
pulisher
Mar 12, 2025

Canada cancels Novavax Covid vaccine purchase - New Vision

Mar 12, 2025
pulisher
Mar 12, 2025

Canada cancels purchase of Covid-19 vaccine from Novavax - БГНЕС

Mar 12, 2025
pulisher
Mar 12, 2025

Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates - Simply Wall St

Mar 12, 2025
pulisher
Mar 12, 2025

Head to Head Analysis: TScan Therapeutics (NASDAQ:TCRX) versus Novavax (NASDAQ:NVAX) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Novavax Announces Board Changes and Strategic Shift - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax appoints new chair as James Young retires By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Need To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

Federal government cancels deal with US company to make COVID-19 vaccine in Montreal - Montreal Gazette

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax faces contract termination with Canadian government By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax falls as Canada terminates COVID-19 vaccine purchase deal - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Canada Cancels Novavax Covid Vaccine Purchase - Barron's

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax Faces Contract Termination with Canadian Government - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax: retirement of the Chairman of the Board of Directors -March 11, 2025 at 09:55 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax faces contract termination with Canadian government - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax Chair James Young Retires; Margaret McGlynn Named Successor -March 11, 2025 at 09:02 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax appoints new chair as James Young retires - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Novavax Reshapes Leadership: Vaccine Industry Veteran Takes Board Chair Amid Strategic Shift - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

Novavax Applies Lessons Learned From Turbulent COVID-19 Experience - BioSpace

Mar 10, 2025

Novavax Inc Stock (NVAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):